Hirudin market report

Page 1

Hirudin Market Report This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.

Scope of the Report: This report focuses on the Hirudin in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.

Market Segment by Manufacturers, this report covers         

The Medicines Company Keyken Minapharm Abbott SALUBRIS Pfizer, Inc Teva Pharmaceutical Industries Ltd DUOPUTAI Pentapharm

Market Segment by Countries, covering       

China Japan Korea Taiwan Southeast Asia India Australia

Market Segment by Type, covers  

Natural Hirudin Recombinant Hirudin

Market Segment by Applications, can be divided into   

Thrombosis Disease Tumor Disease Others

To get Sample Report Visit @ https://www.reportsmonitor.com/request-sample/?post=219413 There are 19 Chapters to deeply display the Asia-Pacific Hirudin market. Chapter 1, to describe Hirudin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Hirudin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.